Table 2 Circulating levels of CTRPs of participants in CAD and non-CAD groups.

From: Implications of C1q/TNF-related protein superfamily in patients with coronary artery disease

Variable

Non-CAD

CAD

P

Yong

Elder

Single-vessel-Lesion

Double-vessel-Lesion

Triple-vessel-Lesion

CTRP1 (ng/ml)

5.28 ± 3.52

6.69 ± 5.36

6.32 ± 6.22

8.25 ± 9.26

11.31 ± 9.99a**

0.019

CTRP5 (ng/ml)

8.95 ± 3.18

9.82 ± 4.23

14.69 ± 14.36

10.75 ± 4.71

10.26 ± 10.00

0.080

CTRP7 (ng/ml)

44.81 ± 41.02

20.83 ± 23.72**

29.70 ± 51.53**

34.83 ± 53.62**

38.21 ± 78.17**

0.005

CTRP15 (ng/ml)

50.21 ± 34.79

40.40 ± 42.08*

40.40 ± 38.18*

26.82 ± 31.85***

27.29 ± 29.48***

<0.001

  1. **p < 0.01 Comparison with non-CAD control subjects. a, p < 0.05 Comparison between single-vessel and triple-vessel.
Back to article page